Sanofi has drafted in Brunswick to handle financial and corporate PR while Aventis is using Financial Dynamics for advice on the unsolicited approach.
Nobody at Sanofi would comment on details of the deal, but a spokeswoman confirmed that the company had engaged Brunswick. It is understood that Brunswick founder Alan Parker, managing partner James Bradley and partner Ruric Ingram were brought in last week to handle the account.
The Brunswick team is reporting to Sanofi head of strategy Jean-Claude Leroy, and the company’s head of comms Nicole Cranois.
An Aventis spokesman said that FD had been working for the organisation on a number of projects over several years but was now advising on the current situation.
Last week (28 January) Aventis said that its supervisory board had unanimously concluded that Sanofi’s bid for the company was not in the interests of shareholders or employees. One of the 15 supervisory board members at the meeting was a representative of Kuwait Petroleum Corp, Aventi’s largest individual shareholder.
If Sanofi is successful the deal would create the world’s third largest drugs company after Pfizer and GlaxoSmithKline.